DiaMedica Therapeutics Inc (DMAC)
3.17
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
3.18
+0.01
(+0.32%)
After-Hours: 20:00
DiaMedica Therapeutics Cash from Operations (Quarterly): -6.653M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -6.653M |
| December 31, 2023 | -3.812M |
| September 30, 2023 | -4.797M |
| June 30, 2023 | -5.03M |
| March 31, 2023 | -5.089M |
| December 31, 2022 | -2.766M |
| September 30, 2022 | -2.361M |
| June 30, 2022 | -2.496M |
| March 31, 2022 | -3.888M |
| December 31, 2021 | -2.804M |
| September 30, 2021 | -3.046M |
| June 30, 2021 | -2.089M |
| March 31, 2021 | -4.313M |
| December 31, 2020 | -3.016M |
| September 30, 2020 | -2.347M |
| June 30, 2020 | -0.844M |
| March 31, 2020 | -2.978M |
| December 31, 2019 | -1.865M |
| September 30, 2019 | -1.232M |
| June 30, 2019 | -2.871M |
| March 31, 2019 | -3.134M |
| December 31, 2018 | -1.90M |
| September 30, 2018 | -1.838M |
| June 30, 2018 | -1.023M |
| March 31, 2018 | -0.935M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.9748M |
| September 30, 2017 | -0.679M |
| June 30, 2017 | -1.423M |
| March 31, 2017 | -0.8232M |
| December 31, 2016 | -1.267M |
| September 30, 2016 | -0.9309M |
| June 30, 2016 | -0.3946M |
| March 31, 2016 | -0.3942M |
| December 31, 2015 | -0.543M |
| September 30, 2015 | -0.1823M |
| June 30, 2015 | -0.4988M |
| March 31, 2015 | -0.3392M |
| December 31, 2014 | -0.1242M |
| September 30, 2014 | -2.450M |
| June 30, 2014 | -0.0411M |
| March 31, 2014 | -1.14M |
| December 31, 2013 | -0.4561M |
| September 30, 2013 | -1.122M |
| June 30, 2013 | -2.065M |
| March 31, 2013 | -1.860M |
| December 31, 2012 | -1.444M |
| September 30, 2012 | -1.956M |
| June 30, 2012 | -1.400M |
| March 31, 2012 | -0.6838M |
| December 31, 2011 | -1.252M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-6.653M
Minimum
Mar 2024
-0.844M
Maximum
Jun 2020
-3.215M
Average
-2.924M
Median
Cash from Operations (Quarterly) Benchmarks
| NextCure Inc | -12.61M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -4.881M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 4.208M |
| Cash from Financing (Quarterly) | -0.001M |
| Free Cash Flow | -20.32M |
| Free Cash Flow Per Share (Quarterly) | -0.1755 |
| Free Cash Flow Yield | -18.15% |